Stanford physician Samuel LeBaron discusses his book, which covers death and how to prepare for and receive end-of-life care.
As FDA weighs a ban on menthol in cigarettes, study shows how the tobacco industry targeted products to women, teens and Black people.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Stanford physician Lucy Kalanithi opens up about loss, grief and love for her neurosurgeon husband, Paul, five years after his death from lung cancer.
Stanford researchers are working on a test to identify early-stage lung cancer by detecting tumor-specific mutations in bits of DNA in the bloodstream.
Scientists create a new 3D lung cancer model to better reveal the drivers of cancer, and in doing so, find a new gene that may be a possible drug target.
Scientists at Stanford have developed a new PET scan tracer that flags both pancreatic cancer and a lung disease known as idiopathic pulmonary fibrosis.
In response to views that cigarettes were unhealthful, tobacco companies used images of medical professionals to sell their products.
When Stanford's James Spudich was diagnosed with lung cancer, one of his first thoughts was of his colleague, lung development expert Mark Krasnow. Within hours a group of Stanford scientists had launched an astoundingly comprehensive study of healthy and diseased human lung tissue from one of their own.